FHL5 anticorps (N-Term)

N° du produit ABIN636206

Détail du produit anti-FHL5 anticorps

Antigène: FHL5 (Four and A Half LIM Domains 5 (FHL5))

Épitope: N-Term

Reactivité: Mammifères

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FHL5 est non-conjugé

Application: Western Blotting (WB)

Purification: Affinity chromatography purified

Immunogène: ACT antibody was raised in rabbit using N terminus of ACT as the immunogen.

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Détails sur FHL5

Antigène: FHL5 (Four and A Half LIM Domains 5 (FHL5))

Autre désignation: ACT (FHL5 Produits)

Synonymes: anticorps MGC82038, anticorps FHL5, anticorps act, anticorps ACT-1, anticorps ACT, anticorps RP3-393D12.2, anticorps dJ393D12.2, anticorps 1700027G07Rik, anticorps Act, anticorps four and a half LIM domains 5, anticorps four and a half LIM domains 5 L homeolog, anticorps agmatine coumaroyltransferase, anticorps FHL5, anticorps fhl5.L, anticorps fhl5, anticorps ACT, anticorps Fhl5

Sujet: Transcriptional activation of CREB and CREM are required for proper cellular differentiation. A novel protein, activator of CREM in testis (ACT), is expressed with CREM.